The Urticaria Severity Score: A sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria

Annals of Allergy, Asthma and Immunology

Volumn 102, Issue 6, 2009, Pages 475-482

  Jariwala, Sunit P ^a,b   Moday, Heather ^a   De Asis, M Lourdes ^a   Fodeman, Jason ^a   Hudes, Golda ^a   De Vos, Gabriele ^a   Rosenstreich, David ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID;

ADULT; ARTICLE; CHRONIC URTICARIA; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; THERAPY EFFECT; TREATMENT RESPONSE; URTICARIA SEVERITY SCORE;

EID: 67549109369     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60120-2     Document Type: Article

References (20)

1. Greaves MW. Chronic urticaria. N Engl J Med. 1995;322:1767-1772.
2. Fox RW. Update on urticaria and angioedema (hives). Allergy Proc. 1995;16:289-292. (Pubitemid 26020470)
3. O'Donnell BF, Lawlor F, Simpson J, et al. The impact of chronic urticaria on quality of life. Br J Dermatol. 1997;136:197-201. (Pubitemid 27062719)
4. Poon E, Seed PT, Greaves MW, et al. The extent and nature of disability in different urticarial conditions. Br J Dermatol. 1999;140:667-671. (Pubitemid 29191386)
5. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664-672. (Pubitemid 30226438)
6. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2000;84:517-522. (Pubitemid 30365414)
7. Monroe E, Finn A, Patel P, et al. Efficacy and safety of desloratidine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo controlled trial. J Am Acad Dermatol. 2003;48:535-541. (Pubitemid 36397016)
8. Tharp MD. Chronic urticaria: pathophysiology and treatment approaches. J Allergy Clin Immunol. 1996;98:S325-S330. (Pubitemid 27016942)
9. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol. 2002;110:484-488.
10. Grattan CE, Francis DM, Slater NG, et al. Plasmapheresis for severe unremitting chronic urticaria. Lancet. 1992;339:1078-1080.
11. Reeves GE, Boyle MJ, Bonfield J, et al. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J. 2004;34:182-186. (Pubitemid 38651038)
12. Ring J, Hein R, Gauger A, et al. Once-daily desloratadine improves the signs and symptoms of chronic urticaria: a randomized double-blind, placebo-controlled study. Int J Dermatol. 2001;40:72-76. (Pubitemid 32201239)
13. Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol. 2000;43:24-30. (Pubitemid 30439708)
14. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol. 1997;136:305-314. (Pubitemid 27105848)
15. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol. 1997;37:41-50. (Pubitemid 27287692)
16. Staubach P, Eckhardt-Henn A, Dechene M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. 2006;154:294-298. (Pubitemid 43382700)
17. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216.
18. Lennox RD, Leahy MJ. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol. 2004;93:142-146. (Pubitemid 39128493)
19. Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy. 2005;60:1073-1078. (Pubitemid 40942764)
20. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835-840. (Pubitemid 26099607)